Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch-Coached walking at home put to the test for leg artery disease

NCT ID NCT07825168

Symptom relief Sponsor: Grigore T. Popa University of Medicine and Pharmacy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are studying whether a 6-month home walking program can help people with peripheral arterial disease of the legs. Participants wear a smartwatch that counts daily steps and receive weekly phone calls from a researcher who reviews their activity and offers guidance. The study tracks how often participants meet step goals, how far they can walk in 6 minutes, and when leg pain begins during walking. The goal is to see whether this remote approach is practical and whether it improves walking ability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A home-based walking program supported by smartwatch step tracking and weekly telephone coaching
What this could lead to
If the program helps, it could offer a low-cost way for people with peripheral arterial disease to improve walking distance from home, without frequent clinic visits.
What could go wrong
The study is small and has no comparison group, so improvements may reflect participants' motivation rather than the program itself. Walking can also trigger leg pain in this condition, and some people may struggle to stick with the plan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Jan 2023

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. age ≥18 years; 2. diagnosis of PAD, defined by an ankle-brachial index (ABI) ≤0.90, arterial stenosis \>70% documented by angiography, or previous lower-extremity revascularization; 3. ability to safely perform walking exercise at home; 4. ability to use the activity-monitoring device and read the number of daily steps displayed on the device; 5. access to and ability to use a mobile phone for telephone counseling; 6. ability to complete the activity journal; 7. provision of written informed consent. Exclusion Criteria: 1. chronic limb-threatening ischemia (CLTI); 2. locomotor disability preventing participation in the walking exercise program; 3. significant visual or hearing impairment interfering with participation in the in-tervention; 4. moderate-to-severe cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score \<17 \[17\]; 5. requirement for long-term oxygen therapy; 6. incomplete medical records; 7. inability to provide reliable information required for study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral arterial disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peripheral arterial disease

Contacts and locations

Locations

  • Spitalul Clinic de Recuperare Iași

    Iași, Iaşi, 700686, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.